1.
Georgiadou SP,
Sipsas NV,
Marom EM,
Kontoyiannis DP.
The diagnostic value of halo and reversed halo signs for
invasive mold infections in compromised hosts.
Clin Infect Dis.
2011;52:1144– 55.
2.
Gefter WB.
The spectrum of pulmonary aspergillosis.
J Thorac Imag 1992;7:56–74.
3.
Kuhlman JE,
Fishman EK,
Burch PA,
Karp JE,
Zerhouni EA,
Siegelman SS.
Invasive pulmonary aspergillosis in acute leukemia: the contribution of CT to early diagnosis and aggressive management.
Chest 1987;92:95–9.
Glimp RA,
Bayer
4.
AS.
Pulmonary aspergilloma: diagnostic and therapeutic considerations.
Arch Intern Med
1983;143:303–8.)
5.
De Pauw B,
Walsh TJ,
Donnelly JP,
Stevens DA,
Edwards JE,
Calandra T,
et al.
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
Clin Infect Dis.
2008;46: 1813-21.
doi: 0.1086/588660.
6.
Marr KA,
Laverdiere M,
Gugel A,
Leisenring W.
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.
Clin Infect Dis.
2005;40: 1762-9.
doi:10.1086/429921.
7.
Vergidis P,
Razonable RR,
Wheat LJ,
Estes L,
Caliendo AM,
Baden LR,
et al.
Reduction in falsepositive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.
J Clin Microbiol.
2014;52: 2199-201.
doi:10.1128/JCM.00285-14.
8.
Shibuya K,
Ando T,
Hasegawa C,
et al.
Pathophysiology of pulmonary aspergillosis.
J Infect Chemother 2004; 10:138–45.
9.
Brook O,
Guralnik L,
Hardak E,
et al.
Radiological findings of early invasive pulmonary aspergillosis in immunecompromised patients.
Hematol Oncol 2009; 27:102–6.
10.
Caillot D,
Couaillier JF,
Bernard A,
et al.
Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia.
J Clin Oncol 2001; 19:253–9.
11.
Kuhlman JE,
Fishman EK,
Siegelman SS.
Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT,
the CT halo sign,
and the role of CT in early diagnosis.
Radiology 1985; 157:611–14.
12.
Brodoefel H,
Vogel M,
Hebart H,
et al.
Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome.
AJR Am J Roentgenol 2006; 187:404–13.
13.
Legouge,
C.,
Caillot,
D.,
Chrétien,
M.
L.,
Lafon,
I.,
Ferrant,
E.,
Audia,
S.,
...
& Maitre,
T.
(2013).
The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?.
Clinical infectious diseases,
58(5),
672-678.
14.
Caillot,
D.,
Valot,
S.,
Lafon,
I.,
Basmaciyan,
L.,
Chretien,
M.
L.,
Sautour,
M.,
...
& Dalle,
F.
(2016,
October).
Is It Time to Include CT “Reverse Halo Sign” and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?.
In Open forum infectious diseases(Vol.
3,
No.
4).
Oxford University Press.
15.
Wahba H,
Truong MT,
Lei X,
Kontoyiannis DP,
Marom EM.
Reversed halo sign in invasive pulmonary fungal infections.
Clin Infect Dis.
2008;46:1733–7.
16.
Jung J,
Kim MY,
Lee HJ,
Park YS,
Lee S-O,
Choi S-H,
et al.
Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis.
Clin Microbiol Infect.
2015;21:684.
e11–8.
17.
Horger M,
Einsele H,
Schumacher U,
Wehrmann M,
Hebart H,
Lengerke C,
et al.
Invasive pulmonary aspergillosis: frequency and meaning of the Bhypodense sign^ on unenhanced CT.
Br J Radiol.
2005;78:697–703.
18.
Sassi,
C.,
Stanzani,
M.,
Lewis,
R.
E.,
Facchini,
G.,
Bazzocchi,
A.,
Cavo,
M.,
& Battista,
G.
(2018).
The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies.
The British journal of radiology,
91(1082),
20170220.
19.
Sonnet S,
Buitrago-Téllez CH,
Tamm M,
Christen S,
Steinbrich W.
Direct Detection of Angioinvasive Pulmonary Aspergillosis in immunosuppressed Patients: Preliminary Results with High-Resolution 16-MDCT Angiography.
AJR Am J Roentgenol.
2005;184: 746-51.
doi:10.2214/ajr.184.3.01840746.
20.
Stanzani M,
Battista G,
Sassi C,
Lewis RE,
Tolomelli G,
Clissa C,
et al.
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies.
Clin Infect Dis.
2012;54: 610-6.
doi:10.1093/cid/cir861.
21.
Stanzani M,
Sassi C,
Lewis RE,
Tolomelli G,
Bazzocchi A,
Cavo M,
et al.
High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies.
Clin Infect Dis.
2015;60: 1603-10.
doi:10.1093/cid/civ154.